huSCAP Mouse
製品名
huSCAP Mouse
製品ID
C001950
系統名
C57BL/6NCya-Scaptm1(hSCAP)/Cya
背景情報
C57BL/6NCya
状況
このマウス系統を論文で使用する場合は、「huSCAP Mouse（カタログ番号C001950）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
遺伝子名
遺伝子別名
--
NCBI ID
染色体
Chr 3
MGI ID
さらに
系統詳細
The SCAP gene (SREBP cleavage-activating protein) encodes a critical regulatory protein that functions as a sterol sensor and escort within the cell. Primarily expressed in the liver, brain, and endocrine tissues, the SCAP protein resides in the endoplasmic reticulum (ER) membrane, where it forms a complex with SREBP (Sterol Regulatory Element-Binding Protein) [1]. When cellular cholesterol levels are low, SCAP undergoes a conformational change that allows it to escort SREBPs to the Golgi apparatus for activation, thereby triggering the expression of genes involved in lipid synthesis [2]. Conversely, high sterol levels cause SCAP to bind to INSIG proteins, anchoring the complex in the ER and halting lipid production [3]. Due to its central role in metabolic homeostasis, dysregulation of the SCAP gene is associated with metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and hyperlipidemia, while specific mutations have been linked to autosomal dominant hypercholesterolemia.
huSCAP mice are humanized models generated using gene editing technology by replacing the sequences from upstream of exon 1 to 3’UTR of the mouse Scap gene with the sequences from upstream of exon 1 to 3’UTR of the human SCAP gene. This strain can be used for studying the pathological mechanisms and treatments of metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), autosomal dominant hypercholesterolemia, and hyperlipidemia, as well as for the development of SCAP-targeted drugs.
参考文献
Kober DL, Radhakrishnan A, Goldstein JL, Brown MS, Clark LD, Bai XC, Rosenbaum DM. Scap structures highlight key role for rotation of intertwined luminal loops in cholesterol sensing. Cell. 2021 Jul 8;184(14):3689-3701.e22.
Xu S, Smothers JC, Rye D, Endapally S, Chen H, Li S, Liang G, Kinnebrew M, Rohatgi R, Posner BA, Radhakrishnan A. A cholesterol-binding bacterial toxin provides a strategy for identifying a specific Scap inhibitor that blocks lipid synthesis in animal cells. Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2318024121.
Gao Y, Zhou Y, Goldstein JL, Brown MS, Radhakrishnan A. Cholesterol-induced conformational changes in the sterol-sensing domain of the Scap protein suggest feedback mechanism to control cholesterol synthesis. J Biol Chem. 2017 May 26;292(21):8729-8737.
系統作製戦略
The sequences from upstream of exon 1 to 3’UTR of the mouse Scap gene were replaced with the sequences from upstream of exon 1 to 3’UTR of the human SCAP gene.
Figure 1. Diagram of the gene editing strategy for the generation of huSCAP mice.
適用分野
Screening, development, and preclinical evaluation of SCAP-targeted drugs;
Research on the pathological mechanisms and treatment methods of diseases such as metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), autosomal dominant hypercholesterolemia, and hyperlipidemia.
お問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。